Moderna
MRNA
$44.40
Share price
-2.09%
Change (1 day)
-74.77%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.
Market capitalization of Moderna (MRNA)
Market cap: NZ$17.16 Billion
As of April 2025 Moderna has a market cap of NZ$17.16 Billion. This makes Moderna the world's 1616th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Moderna from 2018 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | NZ$17.16 B | -37.32% |
| 2024 | NZ$27.38 B | -54.33% |
| 2023 | NZ$59.95 B | -44.83% |
| 2022 | NZ$108.68 B | -27.91% |
| 2021 | NZ$150.76 B | 163.14% |
| 2020 | NZ$57.29 B | 486.18% |
| 2019 | NZ$9.77 B | 30.58% |
| 2018 | NZ$7.48 B |
End of Day market cap according to different sources
On Apr 15th, 2025 the market cap of Moderna was reported to be:
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 | NZ$0.21 B | -98.73% | 🇺🇸 USA |
 | NZ$333.74 B | 1,844.41% | 🇺🇸 USA |
 | NZ$1.4 M | -99.99% | 🇺🇸 USA |
 | NZ$50.56 B | 194.61% | 🇺🇸 USA |
 | NZ$369.31 B | 2,051.65% | 🇨🇭 Switzerland |
 | NZ$2.99 B | -82.58% | 🇺🇸 USA |
 | NZ$626.34 B | 3,549.10% | 🇺🇸 USA |
 | NZ$5.03 B | -70.65% | 🇺🇸 USA |